over the last x number of months i have been trying to draw your attention to hdrn. this came out today and i would encourage you to look hard at the company and get their annual report w/the letter to shareholders. biodefense is going to be BIG and they are IN THERE.:
(COMTEX) B: Hadron Subsidiary Awarded Bioterrorism Training Developme
B: Hadron Subsidiary Awarded Bioterrorism Training Development Contract by the
University of Alabama at Birmingham
ALEXANDRIA, Va., Dec 6, 2000 /PRNewswire via COMTEX/ -- Hadron, Inc. (OTC
Bulletin Board: HDRN) today announced that its Advanced Biosystems, Inc.
subsidiary has won a contract award from the University of Alabama at Birmingham
to provide support for the development of a training course for medical
practitioners who may be faced with "rare events," such as bioterrorism. This
work will be funded by the Agency for Healthcare Research and Quality, an agency
of the U.S. Department of Health and Human Services.
The training course is targeted to enhance the ability of medical professionals
to identify and treat a wide variety of rare and potentially fatal diseases.
Advanced Biosystems' expertise with these rare infectious diseases will be used
to develop the initial course outline and provide subject matter expertise for
the course content. Advanced Biosystems' President, Dr. Ken Alibek, said, "We
are glad to collaborate with the excellent researchers and scientists at the
University of Alabama at Birmingham in the development of this significant
program for biodefense education."
"We are pleased that Dr. Ken Alibek and his team of scientists and other
experts, have been chosen to work on curriculum development for an area that is
so key to our national security," said Jon M. Stout, Hadron's President and
Chief Executive Officer. "The value of the contract is not material to Hadron in
terms of dollars, but is quite important in that we are properly positioned to
pursue larger analytical -- as well as medical -- research contracts in the
field of biowarfare defense. We look forward to providing the Hadron guarantee
of customer satisfaction to our newest partner," he concluded.
Hadron specializes in developing innovative technical solutions for the
intelligence community, analyzing and supporting defense systems (including
intelligent weapons systems and biological weapons defense), and supporting
complex computer systems. The Company's stock trades on the OTC Electronic
Bulletin Board under the symbol HDRN. Hadron can be found on the Internet at
hadron.com . Hadron investor relations can be contacted at
703-329-9400 or via email at agordon@hadron.com.
Except for the historical information contained herein, this press release
contains forward-looking statements within the meaning of Section 21E of the
Securities and Exchange Act of 1934, as amended, that involve a number of risks
and uncertainties. These forward-looking statements may be identified by
reference to a future period by use of forward-looking terminology such as
"anticipate," "expect," "could," "intend," "may" and other words of similar
nature. There are certain important factors and risks that could cause results
to differ materially from those anticipated by the statements contained herein.
Such factors and risks include business conditions and growth in the information
services, engineering services, software development and government contracting
arenas and in the economy in general. Competitive factors include the pressures
toward consolidation of small government contracts into larger contracts awarded
to major, multi-national corporations; and the Company's ability to continue to
recruit and retain highly skilled technical, managerial and sales/marketing
personnel. Other risks may be detailed from time to time in the Company's
filings with the Securities and Exchange Commission. Hadron undertakes no
obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
SOURCE Hadron, Inc.
CONTACT: Amber Gordon of HADRON, INC., 703-329-9400, ext. 311, or emai
:
agordon@hadron.com
URL: hadron.com
prnewswire.com
(C) 2000 PR Newswire. All rights reserved.
-0-
KEYWORD: Virginia
Alabama
INDUSTRY KEYWORD: CPR
BIO
SUBJECT CODE: CON
*** end of story *** |
